Alex Shved
37-year-old Etobicoke resident with stage 4 (metastatic) melanoma who challenged Ontario's refusal to fund out-of-country TIL therapy. He represented himself at the September 8, 2026 hearing; the Divisional Court quashed the denial on September 22, 2026 and ordered a new decision by October 2.
Connected Scandals
Ontario refused to pay for Alex Shved, a Toronto father with stage 4 melanoma, to get a Health Canada-approved cell therapy in the U.S. On Sept 22, 2026, a three-judge Divisional Court panel quashed that refusal as unreasonable and ordered a new decision by Oct 2, noting he "will likely be dead by Christmas" without treatment.
Ontario denied Shved out-of-country funding for tumour-infiltrating lymphocyte (TIL) therapy, a Health Canada-approved treatment for his stage 4 melanoma. He sought judicial review and represented himself at the September 8, 2026 hearing. On September 22, 2026, the Divisional Court quashed the denial as unreasonable and ordered a new decision by October 2, finding the record showed he "will likely be dead by Christmas if he does not receive the requested treatment within a few weeks" (Star, Globe).